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Abstract: Regulatory T cells (Treg) are mandatory elements in the maintenance of human pregnancy,
but their de novo differentiation has not been completely exposed. HSPE1 chaperone expressing
trophoblast cells may have a role in it. Trophoblast-derived extracellular vesicles (EVs), either at the
feto–maternal interface or in circulation, target CD4+ T cells. We hypothesized that HSPE1-associated
trophoblastic cell line (BeWo)-derived EVs are active mediators of Treg cell differentiation. We proved
at first that recombinant HSPE1 promote human Treg cell differentiation in vitro. Developing a
CRISPR-Cas9 based HSPE1 knockout BeWo cell line we could also demonstrate, that EV-associated
HSPE1 induces Treg development. Next-generation sequencing of miRNA cargo of BeWo-EVs
characterized the regulatory processes of Treg polarization. By the use of single-cell transcriptomics
analysis, seven Treg cell subtypes were distinguished and we demonstrated for the first time that
the expression level of HSPE1 was Treg subtype dependent, and CAPG expression is characteristic
to memory phenotype of T cells. Our data indicate that HSPE1 and CAPG may be used as markers
for identification of Treg subtypes. Our results suggest, that trophoblastic-derived iEVs-associated
HSPE1 and miRNA cargo have an important role in Treg cell expansion in vitro and HSPE1 is a useful
marker of Treg subtype characterization.
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1. Introduction
During human pregnancy the maternal immune system has to fine balance itself, in order to
develop and maintain immune tolerance toward the semi-allograft fetus. An ongoing equilibrium
between proinflammatory and anti-inflammatory stimuli characterize the immune system, and a
tolerogenic environment is essential for the maintenance of pregnancy [1,2]. Immune suppressive
Treg cells are crucial players of peripheral tolerance [3]. Treg cells are found at high levels in decidual
tissues, and recently it has been described that in vitro co-culture of extravillous trophoblast cells
with blood derived CD4+ T cells induces Treg cell differentiation [4]. Nevertheless, it has not been
clearly demonstrated what mechanisms are involved in the de novo differentiation of Treg cells at
the feto–maternal interface [5,6]. Although the generation of peripheral Treg cells is less clearly
understood [7], intercellular communication may have an important role in it. [8,9]. One of the most
dynamic forms of intercellular communication is mediated by extracellular vesicles (EVs) [10]. EVs
released by cells are heterogeneous in size, the two most well-studied subtypes are the intermediate-sized
Int. J. Mol. Sci. 2019, 20, 3457; doi:10.3390/ijms20143457 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 3457 2 of 12
EVs (size range 150–800 nm, iEVs) and small EVs (size range 35–150 nm, sEVs) [11]. The placenta is
an abundant and transient source of EVs [12]. On the other hand, the key feature of the protective
environment is particularly realized at the placental level via the establishment and maintenance
of tolerance.
Trophoblast cells highly express the HSPE1 protein [13]. The main annotated role of HSPE1 is the
chaperonin mediated protein folding together with Hsp60 [14]. It has also been suggested that HSPE1
may be critical in the suppression of T cell activation [15]. In myocytes, it has been also described that
HSPE1 inhibits the proapoptotic activity of cells and shifts the cell fate balance toward survival [16].
It has also been proposed that HSPE1 is selectively released from proliferating cells and is an active
player of cell signalling network [15]. Recombinant HSPE1 selectively binds to human CD4+ T cells
in vitro [17] and can induce Treg differentiation in mouse animal model [18]. Besides proteins, miRNAs
are the most important molecular cargo of EVs [19]. miRNAs dynamically regulate the expression
of gene networks (1) and contribute to the function of cell differentiation at the posttranscriptional
level [20]. EV-associated miRNome is regarded as one of the most promising clinical biomarker for
diagnosis, prognosis, and therapeutic options [21]. On the basis of these data, we hypothesized that
trophoblast-derived EV-associated HSPE1 and miRNA cargo specify the generation and heterogeneity
of Treg cells at the feto–maternal interface.
2. Results
2.1. miRNA and Protein Pattern of BeWo-Derived EVs
Altogether we detected 255 common miRNAs by next generation sequencing in BeWo-derived
iEVs and sEVs. There were 111 unique miRNAs to iEV fraction and 20 miRNAs in the sEV fraction,
however none of these miRNAs are known to have immunoregulatory functions. Therefore, we
focused on the common miRNA pattern. All 46 miRNA gene transcripts of the trophoblast-specifically
expressed C19MC cluster were detected in both iEV and sEV fraction miRNA pattern (Figure 1A,
C, n = 3). Hsa-miR-23b is also expressed in EVs, which inhibits the Th17 signalling. Hsa-miR-146a
and hsa-miR-155 which are critical in Treg cells were found in the EV fractions. Hsa-miR-22 and
hsa-miR-221, known as tolerance-associated miRNAs were highly expressed in EVs (Figure 1A,B).
All members of the hsa-miR-17-92 polycistronic miRNA cluster, of critical value in differentiation of
antigen-specific IL-10 producing Treg cells were detectable in EVs (Figure 1A,D).
We identified by mass spectrometry 81 proteins in iEV and 31 proteins in the sEV fraction. We found,
in the iEV fraction, 27 proteins related to immune system process (GO:0002376, p = 2.09 × 10−5), out
of these proteins 16 are associated with leukocyte activation (GO:0045321, p = 2.89 × 10−5) and 29
proteins associated with cell differentiation (GO:0030154, p = 0.0013). De novo protein folding protein,
HSPE1 (GO:0006458, p = 0.00072) was also identified in the iEV samples (Figure 2A). The presence of
HSPE1 was validated by flow cytometry and it was detected both on the exofacial surface and in the
intra-vesicular compartment of iEVs (Figure 2B). HSPE1 was unique to the iEV fraction, it could not be
detected in sEVs (Supplementary Figure S1).
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Figure 1. miRNA content of trophoblastic-derived EVs. (A) Overview of miRNAs found in 
trophoblastic (BeWo cells)-derived EVs and their cell differentiation-associated target genes. In the 
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Figure 1. miRNA content of trophoblastic-derived EVs. (A) Overview of miRNAs found in trophoblastic
(BeWo cells)-derived EVs and their cell differentiation-associated target genes. In the upper left miRNAs
involved in the immunological tolerance are displayed. In the lower left, the miR17-92 cluster and,
on the right, the placental-specific C19MC cluster are showed. Red dots mark the target genes of the
miRNAs. (B) Expression of miRNAs involved in immunological tolerance (expression is given in reads
per million (RPM), n = 3) (C) Expression of miRNAs on the C19MC miRNA cluster, showing that most
of the miRNAs are showing a higher expression in the iEV fraction. (D) Expression of miR17-92 cluster
(expression is given in reads per million (RPM), n = 3).
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Figure 2. HSPE1 content of BeWo iEVs. (A) Protein interaction network of proteins found in
Bewo-derived iEVs. Dark blue color represents the proteins involved in immune system processes,
light blue color marks the proteins involved in leukocyte activation, and the proteins playing a role
in protein folding (k-mean clustering) are indicated in yellow. (B) FACS-based validation of HSPE1
association with BeWo-derived iEVs.
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2.2. Recombinant HSPE1 (rHSPE1) and iEVs Induce Human Treg Cell Expansion In Vitro
rHSPE1 induced CD25+CD127lo Treg cell expansion from human CD4+ T cells. We found that
10 µg/ mL of rHSPE1 is the most potent concentration for in vitro Treg cell expansion (rHSPE1 8.07± 0.53
% vs. untreated 1.98 ± 0.02%) (Figure 3A,B). In vitro generated CD25+CD127lo Treg cells were sorted
and showed viability by having positive migratory and motility capacity for 3 h under holomicroscopic
analysis (Supplementary Figure S2).
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Figure 3. rHSPE1, BeWo GFP-iEV, and BeWo HSPE1 KO-iEV induced Treg differentiation from CD4+
Th cells. (A) Representative FACS dot plot showing the expanded Treg cell population (defined as
CD25+CD127lo) upon rHSPE1 treatment (x-axis showing the expression of CD25, y-axis showing
the expression of CD127). (B) Concentration dependent Treg cell expansion upon rHSPE1 treatment.
(C) Treg cell expansion upon GFP control transfected-derived iEVs (abbreviated as GFP) and HSPE1
KO-derived iEVs (abbreviated as HSPE1-KO).
To decide whether HSPE1 induced Treg generation is associated with iEVs, we have developed an
HSPE1-KO BeWo cell line construction. We transfected the BeWo cells with either GFP control plasmid
or HSPE1 targeting sgRNA. Transfection efficiency was validated with Sanger sequencing and qPCR
(Supplementary Figure S3). iEVs isolated from GFP transfected BeWo cells induced Treg cell expansion
comparable to the rHSPE1 protein (5.36%), however iEVs isolated from HSPE1 KO BeWo cells caused
a similar effect as untreated control (1.85%) (Figure 3C).
2.3. HSPE1 is Differentially Expressed in the Treg Subtypes
To address the whether HSPE1 plays a role in the maintenance of Treg cells we used of single-cell
transcriptomic approach. The analysis showed that all seven Treg cell subtypes expressed the HSPE1
among CD4+C 25+ Treg cells. HSPE1 showed a cluster dependent expression (Figure 4A,B). To compare
how does the expression of HSPE1 observed in Treg cells relate to CD4+ cells and peripheral blood
mononuclear cells (PBMCs) we applied the marker genes identified in the Treg single-cell data to CD4+ T
cells and could successfully differentiate three Treg cell subtypes in this dataset: naïve, activated/effector,
and memory Treg cells (Figure 4C,D).
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Figure 4. Regulatory T cell heterogeneity revealed by single cell transcriptomics. (A) UMAP clustering
of Treg cells subsets. (B) Treg cell subtype dependent expression of HSPE1. (C) UMAP clustering
of CD4+ T cell subsets, blue arrows showing identified Treg cell subsets. (D) CD4+ T cell subsets
dependent expression of HSPE1. (E) UMAP clustering of PBMCs, blue arrow showing memory Treg
cell population and green points showing naïve Treg cell population dispersed in CD4+ naïve cells.
(F) PBMCs subsets dependent expression of HSPE1.
Furthermore, we went on and successfully identified two Treg cell clusters in PBMCs: naïve Treg
and memory Treg cells based on the subtype-specific marker genes identified in the CD4+CD25+ Treg
cells. With our approach, we could also identify the naïve Treg cells among naïve T cells (Figure 4E,F).
In all three datasets, the HSPE1 expression was Treg cell dependent, and we also identified the CAPG
expression as a memory Treg and memory T cell-specific among T cells, suggesting the expression
of HSPE1 and CAPG as possible Treg subtype markers. To summarize, the single-cell transcriptomic
analysis suggests that HSPE1 may have a maintenance role in Treg cells, however this hypothesis needs
to be confirmed by further downstream analysis.
3. Discussion
Regulatory T cells play a central role in the induction and maintenance of maternal immune
tolerance during pregnancy. Treg cells inhibit (1) the proliferation and cytokine production in both
effector CD4+ and CD8+ T cells, (2) the immunoglobulin production by B cells, (3) the cytotoxic
activity of natural killer (NK) cells, and (4) the maturation of dendritic cells (DC) [22]. miRNAs are
small non-coding RNA molecules which are potent regulators of gene networks. They are released
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into the extracellular space and systemic circulation, contributing to tissue homeostasis and disease
pathophysiology. They may be packaged into EVs or may bind to proteins including argonaute-2 (Ago2),
nucleophosmin1, or high-density lipoproteins. The largest cluster of miRNAs in the human genome is
the chromosome 19 miRNA cluster (C19MC) which is highly expressed in the human placenta. The
rapid decline of C19MC miRNAs after delivery has been described [23]. Among all human placental
miRNAs, the members of the C19MC cluster have the highest expression levels [24]. C19MC cluster is
also expressed in trophoblastic placental cell lines, including the choriocarcinoma cell lines JEG3, JAr,
and BeWo. We demonstrated, that all members of the C19MC cluster are expressed in BeWo-derived
EVs and their expression levels were the highest among BeWo-EV-associated miRNAs. We could also
identify the presence of hsa-miR-221 and hsa-miR22, which are tolerance-associated miRNAs, through
silencing of inflammatory genes and chromatin remodelling. We could also determine the presence of
hsa-miR-155, that is highly expressed in Treg cells and plays a role in Treg cell proliferation via targeting
SOCS1 [25]. The presence of miR-17-92 polycistronic miRNA cluster (hsa-miR 17, 18a, 19a, 20a, and
92) also confirmed the effects of BeWo-iEVs in Treg differentiation because of it is an indispensable
influence in antigen-specific IL-10 production of Treg cells. [1]. miRNAs that play an important role in
Treg cell functions were also revealed, including hsa-miR146a, which is necessary for Treg mediated
suppression [26] and hsa-miR-23b, which is a competent suppressor of Th17 signalling.
We have identified by mass spectrometry the presence of HSPE1 protein and confirmed the
presence of HSPE1 both on the surface of iEVs and in the vesicular lumen by a flow cytometric
approach. The presence of HSPE1 has been reported in B-cell derived sEVs [27] and cancer cell-derived
EVs [28–30] by mass spectrometric analysis, but the function of EV-associated HSPE1 has not been
evaluated. In our proteomic analysis, we have identified proteins involved in the biogenesis of
iEVs (enriched in microvesicles), including annexins (ANXA2, ANXA5), Rab proteins (RAB1A), and
ADP-ribosylation factors (ARF1).
As it was previously reported recombinant mouse HSPE1 induces regulatory T cell differentiation
in vitro [18]. In our experiments, we investigated this phenomenon in human experimental systems [17].
We proved that human rHSPE1 induced Treg cell differentiation in vitro too and trophoblastic iEVs
associated HSPE1 could also mediate this effect as was confirmed by the using of HSPE1 KO cell
line. Understanding the molecular mechanisms that provide the necessary signals for a continuously
regulated active immune cell compartment may pave the way to unravel the highly and tightly
controlled molecular cascade-network events and provide new biomarkers and potent therapies for
the altered molecular event-induced pregnancy-specific disorders.
4. Materials and Methods
4.1. Peripheral Blood Collection
Peripheral venous blood collected in 6mL Vacutainer® EDTA of Becton Dickinson (BD San Jose,
California, USA) from healthy non-pregnant donors (n = 10) was obtained from the Hungarian
National Blood Transfusion Service. The study was approved by the Scientific and Research Ethics
Commission (TUKEB) of Hungary (Approval code: 4834-0/2010-1018EKU; Date of approval: 18.10.2010).
Donor-informed consent was signed by each donor and the guidelines and regulations of the Helsinki
Declaration in 1975 were followed. Peripheral blood mononuclear cells (PBMCs) were separated using
Histopaque®-1077 (Sigma, St. Louis, MO, USA), as a density gradient cell separation medium and
stored at −80 ◦C until use.
4.2. Culturing of BeWo Cells
BeWo cell line (ATCC® CCL-98™) was obtained from American Type Culture Collection. The cells
were cultured in Ham’s F12/K medium supplemented with 2 mM L-glutamine, 10% GIBCO® FBS
(Thermo Fisher Scientific, Waltham, MA, USA), 5% glucose, 1.0 mM sodium pyruvate, 1% of Gibco®
MEM Non-Essential Amino Acids, 100 U/mL penicillin and 100 µg/mL streptomycin (Thermo Fisher
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Scientific, Waltham, MA, USA). Cells were maintained as monolayers in 25 or 75 cm2 flasks at 37 ◦C in
the humidified atmosphere, in the presence of 5% CO2. All chemical reagents were purchased from
Sigma-Aldrich Company (St. Louis, MO, USA).
4.3. Generation of HSPE1 Knockout (HSPE1 KO) BeWo Cells
CRISPR-Cas9 approach was applied to generate the HSPE1 KO BeWo cell line. First, to optimize
the electroporation conditions, we used the Cell Line Optimization 4D-NucleofectorTM X Kit (Lonza,
Cologne, Germany) according to the manufacturer’s instructions. Briefly, BeWo cells were centrifuged
at 90 g for 10 min at room temperature (RT) and the medium was discarded completely. Cell pellets
were resuspended in a cocktail containing 82% Solution SF (or SE or SG) and 18% Supplement obtaining
a cell density of 1.8 × 105 BeWo cells/ 19.6 µL. 0.4 µg of pMaxGFP plasmid vector (1 µg/mL) per 1.8 × 105
BeWo cells was added to the cell suspension. Next, we homogenized the cell suspension by pipetting
up-and-down and added 20 µL of BeWo cells to each well of the nucleocuvette. We ran the cell line
optimization programs within the Nucleofector 4D-X. After nucleofection, we incubated the cells for
10 min at RT. After the incubation period, we added 30 µL 20% FBS containing RPMI-1640 media
and incubated the cells for another 10 min at RT. Cells were transferred to 24 well Tc treated culture
plates (Eppendorf AG, Hamburg Germany) and were analyzed by fluorescent microscopy and FACS
for analysing of GFP signal (success of transfection) and cell viability (assessed by propidium iodide
incorporation by FACS). Based on the optimization data the Supplement SF and transfection program
EN-150 was chosen (viability 85%, transfection success 90%, Supplementary Figure S3). Next synthetic
guide RNAs (sgRNA) were designed to target the HSPE1 gene using Synthego CRISPR Design Tool
(sgRNA-1 G*C*U*GCUGAAACUGUAACCAA and sgRNA-2 U*A*A*ACGCUUGUCCUGCCUGU)
(Synthego Corporation, California, USA, Supplementary Figure S4). sgRNAs were rehydrated in 1x
TE buffer obtaining a concentration of 100 pmol/µL) and the same transfection protocol was used as
described above, with the addition of 20 pmol Cas9 nuclease 2NLS, S. pyogenes (Synthego Corporation,
California, USA)/ well along with sgRNAs. Viability of GFP and HSPE1 KO cells was validated
by FACS.
4.4. Validation of HSPE1 Knockout (HSPE1 KO) BeWo Cells
The transfection efficiency was evaluated and validated by several methods. DNA was isolated
from GFP and HSPE1 KO BeWo cells with Blood/Cell DNA Mini Kit (Geneaid Biotech Ltd., New Taipei,
Taiwan) and the concentration was determined with Qubit 4 fluorometer using the Qubit 1x dsDNA
HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). Sanger sequencing was used to confirm
the indels produced by HSPE1 specific sgRNA-2. Sequencing data were analyzed with Seq Scanner
v2 (Supplementary Figure S4D). The Sanger sequencing data was used for ICE analysis to detect the
indel frequencies and to determine the effectiveness of the transfection reaction (Supplementary Figure
S4C). For gene expression analysis, first total RNA was isolated with RNeasy Mini Kit (Qiagen, Venlo,
The Netherlands) from GFP and HSPE1 KO BeWo cells. The RNA concentration was determined
with Qubit 4 fluorometer using the Qubit™ RNA HS Assay Kit (Thermo Fisher Scientific, Waltham,
MA, USA). Samples were stored at -80 ◦C until cDNA synthesis. From each sample 1000 ng of total
RNA was reverse transcribed with Sensifast cDNA Synthesis Kit (Bioline, London, UK). QPCR using
SensiFAST SYBR Hi-ROX Kit with SYBR Green primers (Supplementary Table S1) were carried out on
an ABI 7900 real-time PCR instrument (Thermo Fisher Scientific, Waltham, MA, USA) according to
the manufacturer’s instructions. Real-time PCR results were calculated according to the following
formula: relative expression level = 2−∆Ct, where ∆Ct = Ct (of gene of interest) − Ct (of housekeeping
gene) with HPRT as an endogenous control.
4.5. EV Isolation and Characterization
EVs were isolated from the supernatant (SN) of BeWo, BeWo GFP transfected and BeWo HSPE1
KO cells cultured in 75 cm2 Tc treated flasks (Eppendorf AG, Hamburg, Germany) for 24 h in FBS
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free cell culture media using differential centrifugation. As a first step to remove the cell debris, the
SN was centrifuged at 800 g for 5 min at RT. Sedimentation of apoptotic bodies at 2000 g for 20 min
at 16 ◦C was followed by the centrifugation of intermediate-sized EVs (iEV) at 12,500 g for 20 min
at 16 ◦C. After washing iEVs small-sized EVs (sEV) were isolated by ultracentrifugation (100,000 g,
70 min, 4 ◦C). The characterization of EVs followed the latest recommendation of the International
Society for Extracellular vesicles [31]. The proteomic, miRNA and dsDNA content of EV fractions
were assessed with Qubit 4 Fluorometer using the Qubit™ Protein Assay Kit, Qubit microRNA Assay
Kit and Qubit 1X dsDNA HS Assay Kit, respectively. The iEV number was quantified by annexin V
staining, by flow cytometry as previously described by us [32] (Supplementary Figure S5).
Protein cargo of EVs was identified by mass spectrometry. Briefly, iEVs and sEVs were resuspended
in HPLC water and subjected to repeated freeze-thaw cycles and digested in solution. The resulting
peptides were cleaned using PierceTM C18 spin columns (Thermo Fisher Scientific, Waltham, MA,
USA) and analyzed using a Waters nanoAcquity UPLC or a Dionex Ultimate 3000 RSLCnano system
coupled to a Bruker Maxis II Q-TOF mass spectrometer (Bruker, Bremen, Germany) with CaptiveSpray
nanoBooster ionization source. Following trapping, peptides were separated on a 25 cm Waters Peptide
BEH C18 nanoACQUITY 1.7 µm particle size UPLC column using gradient elution. Data processing
was performed with ProteinScape 3.0 software (Bruker Daltonik GmbH, Bremen, Germany). Proteins
were identified using Mascot (version Mascot 2.5; Matrix Science, London, UK) search engine against
the Swissprot database (2015_08). The following parameters were used: Homo sapiens taxonomy,
trypsin enzyme, 7 ppm peptide mass tolerance, 0.05 Da fragment mass tolerance, 2 missed cleavages.
Carbamidomethylation was set as fixed modification, while deamidation (NQ) and oxidation (M)
as variable modifications. To identify key networks, genome ontology (GO) term enrichment was
performed on the identified proteins. For gene ontology (GO) and pathway analysis, FunRich software
(Uniprot and Funrich databases) was used [33].
The expression of HSPE1 in iEVs was evaluated by a flow cytometry. For exofacial labelling,
isolated iEV fractions were resuspended in 100 µL of 0.2 µm filtered PBS and were stained with 0.5 µL
of rabbit anti-human HSPE1 monoclonal antibody (Clone: EPR4475, Abcam, Cambridge, UK) for
20 min on ice in dark. After washing the samples with 1mL filtered PBS, samples were centrifuged
(12,500 g, 15 min, 16 ◦C) and the supernatant was discarded completely. iEV pellets were labelled with
1 µL of donkey anti-rabbit IgG-Phycoerythrin antibody (20 min, on ice, in the dark). After washing
iEV pellets were resuspended in 200 µL filtered PBS and analyzed on FACSCalibur flow cytometer.
For intravesicular labelling first isolated iEVs were fixed and permeabilized with 2% paraformaldehyde
for 10 min at room temperature on ice. Then the same procedure as for exofacial labeling was used (to
distinguish the iEVs from dye-aggregates we used the same staining procedure and dye concentration
without EV sample). Gating strategy is presented in Supplementary Figure S6.
To reveal the detailed miRNA content of EVs next-generation miRNA sequencing approach was
applied. BeWo-iEVs were isolated and resuspended in 12 µL of DNase, RNase free water. RNA
was isolated with exoRNeasy Serum/Plasma Midi Kit (Qiagen, Venlo, The Netherlands). The RNA
integrity was evaluated with Agilent Tapestation and samples with RIN values ≥7 were further
processed. For library preparation, multiplex Small RNA Library Prep Kit was used according to the
manufacturer’s instructions. The sequencing was performed on an Illumina MiSeq instrument and the
paired-end read value was > 20 million/sample. Next, we aligned the transcriptome sequence reads to
the reference genome (Ensembl GRCh38 release) with STAR version 2.5.3a using two-pass alignment
mode. The mirBase annotation was used in both mapping and read counting. After alignment, the
reads were associated with known miRNAs and the number of reads assigned to each miRNA was
counted using ‘featureCounts’ from R package ‘Rsubread’. The data were normalized using the TMM
normalization method of the edgeR R/Bioconductor package (R version 3.4.1, Bioconductor version 3.5).
After pre-processing and quality control we analyzed the immunotolerance associated miRNA and
trophoblast specific miRNA content with Funrich 3.1.3 [33], g:Profiler [34], and NetworkAnalyst 3.0 [35].
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4.6. In Vitro Treg Differentiation and Treg Analysis
Frozen PBMCs were thawed and cultured for 1 day in 75 cm2 flask in RPMI-1640 cell culture
media containing 12 mM L-glutamine, 10% GIBCO® FBS (Thermo Fisher Scientific, Waltham, MA,
USA), 100 U/mL penicillin and 100 µg/mL streptomycin. After 1 day, PBMCs were filtered through
70 µm pore sized MACS SmartStrainers (Miltenyi, Biotec GmbH, Bergisch Gladbach, Germany) and
centrifuged at 800 g for 5 min at RT and resuspended in 100 µL of autoMACS Running Buffer (Miltenyi,
Biotec GmbH, Bergisch Gladbach, Germany). PBMCs were incubated with 20 µL of anti-human
CD4-Phycoerythrin conjugated antibody (Sony Biotechnology, Surrey, UK) for 20 min at RT on ice in
dark. After staining, 5 mL of autoMACS Running Buffer was added and the cells were centrifuged at
800 g for 5 min at RT. Cells were resuspended in 1 mL of autoMACS Buffer and sorted on a SONY
SH800S cell sorter (Sony Biotechnology, Surrey, UK) in 15 mL sterile tubes. The sorting efficiency was
97%. 5 × 105 CD4+ cells were pipetted in a 12 well plate in 2mL of cell culture media. CD4+ T cells were
supplemented with 32 IU/mL recombinant human IL-2 (Thermo Fisher Scientific, Waltham, MA, USA)
and activated with bead-to-cell ratio of 1:1 of Dynabeads™ Human T-Activator CD3/CD28 for T Cell
Expansion and Activation (Thermo Fisher Scientific, Waltham, MA, USA). Treatment of CD4+ T cells
with rHSPE1 in different concentrations (1 µg/mL, 2.5 µg/mL, 10 µg/mL, 15 µg/mL) or 1 × 106 annexin
V positive BeWo GFP transfected- derived iEVs or BeWo HSPE1 KO-derived iEVs was given. After
72 h activation, Dynabeads were removed and cells were washed (800 g, 5 min, RT) and stained with
anti-human CD45RO-Phycoerythrin, anti-human CD25-Fluorescein isothiocyanate (FITC), anti-human
CD3- Alexa Fluor® 647, and anti-human CD127-Phycoerythrin/Cyanine7 monoclonal antibodies in
one tube and anti-human HLA-DR Phycoerythrin/Cyanine7 together with anti-human CD25 FITC in
another FACS tube for immunophenotyping and sorting of regulatory T cells (for gating strategy, see
Supplementary Figure S6, for used antibodies see Supplementary Table S2). FACS data were analyzed
with Flowjo v10.3 (Tree Star Inc., OR, USA) software.
4.7. Holomicroscopy of Treg Cells
CD25hi+ CD127lo+ sorted Treg cells were characterized by holomicroscopy (HoloMonitor M4
Phase Holographic Imaging, Lund, Sweden). Five thousand Treg cells were resuspended in 500 µL
of cell culture media and seeded on µ-Slide 8-Well with ibiTreat (Ibidi, Martinsried, Germany) and
incubated for 30 min to allow cell adhesion. Cell migration (the shortest direct distance from the
starting point to the end point (µm)) and motility (the actual way traveled from the starting point to
the end point (µm)) were monitored for 3 h with 60 sec time-lapse intervals. Time-lapse automatic
background thresholding method was used with the minimum error sets algorithm (adjustment = 128)
for evaluation of images. The total number of evaluated images were 180 and the number of evaluated
cells per image was 10. For manual cell identification, objects of the marginal zone were eliminated.
HoloStudio M4 2.5 program was used to analyze data.
4.8. Single-Cell Transcriptomics Analysis
Regulatory T cells, CD4+ T cells and 68K PBMCs datasets were downloaded from 10x Genomics
datasets available on link. Phyton based Scanpy version 1.3.7 was used for pre-processing and data
analysis. For data filtering and quality control the following parameters were used: cell filter <= 200
genes (filtered out cells that have less than 200 genes expressed), genes filter <3 (filter out genes that
are detected in less than 3 cells) and mitochondrial filter <0.05 (filter out cells that have more than 5%
of mitochondrial reads). Afterwards, the highly variable genes (HVG) were identified in the datasets.
Cell were clustered according to the Louvain algorithm (resolution = 0.8). Data were visualized as
Uniform Manifold Approximation and Projection (UMAP). Cell clusters were annotated manually,
using the top 50 genes expressed in each cell cluster and based on the expression of known cell subtype
markers from the literature.
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4.9. Statistics
GraphPad Prism version 7.0 (GraphPad Software, La Jolla California, USA) was used for statistical
analysis. Two-sided Student’s unpaired t-test was used for normally distributed data, and ANOVA
analysis followed by Bonferroni correction was applied for multiple parameter analysis. In the cases of
non-normal distribution data, Mann–Whitney U or Wilcoxon tests were used, while multiple parameter
analysis was calculated by ANOVA test followed by Kruskal–Wallis test. The level of significance was
set at p < 0.05.
The datasets generated during and/or analyzed during the current study are available from the
corresponding author on reasonable request.
5. Conclusions
EVs, as communication modules between trophoblast and maternal immune cells, represent
a continuous dynamic bridge between the mother and the fetus and define the differentiation and
polarization of maternal immune cells during pregnancy. We presented a protein-miRNA hybrid
molecular pattern, highlighting the HSPE1 protein, of trophoblastic-derived extracellular vesicles, that
is highly potent orchestrator of Treg cells differentiation.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/14/
3457/s1.
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